The Latest Breaking News on Pharma

Recent expansion created an additional 80 to 100 new scientific and technical jobs at the facility - and now more have been created

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

As March comes to an end, biotech stocks Exelixis (EXEL), MacroGenics (MGNX), and Puma Biotechnology (PBYI) have been losing momentum. However, given the long-term prospects of the biotechnology industry and the administration’s push to boost domestic biomanufacturing, these biotech stocks could prove to be solid long-term investments. Read more.

Pharmacy chiefs have issued a warning over shortages of medicine cabinet essentials like Calpol, Nurofen as demand is higher than previous years - while the supply is lower

THE number of female bosses in the FTSE 100 is soon to hit double figures for the first time.

Sixty-five jobs will be lost when Macfarlan Smith shuts its plant at Newbie

A further 156 roles have also been safeguarded

A total of £277m has been awarded through the grants

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

Vertex Pharmaceuticals is forming a base and back above its 50-day moving average. VRTX stock ranks third out of 792 biotechs.

Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer.